串珠聚糖在肝细胞癌的分布及其免疫组化阳性判断标准的初探-东南大学学报医学版

串珠聚糖在肝细胞癌的分布及其免疫组化阳性判断标准的初探

单位：1.皖南医学院弋矶山医院,肝胆外科,安徽,芜湖,241001； 2.浙江大学附属第二医院外科,浙江,杭州,310009

分类号：R735.7, R446.61

出版年·卷·期（页码）：2005·24·第二期（85-89）

摘要：

目的:初步建立串珠聚糖(PLC)免疫组织化学(免疫组化)阳性判断标准,探讨PLC在肝细胞癌(HCC)中的分布特征及其与转移复发的关系.方法:用免疫组化SP法检测PLC及其配体碱性成纤维细胞生长因子(bFGF)在HCC中的分布,根据PLC分布特征初步建立阳性判断标准,分析PLC及bFGF表达与HCC临床病理指标及转移复发的关系.结果:初步建立了一种PLC阳性判断标准;PLC在部分HCC中主要表现为基底膜连续和不连续线形染色,部分HCC主要为癌细胞胞质或胞膜棕黄色染色;bFGF主要为HCC癌细胞胞质和胞膜棕褐色染色;癌组织bFGF表达率及PLC和bFGF共同表达率明显高于癌周肝组织(分别为P＜0.05和P＜0.01).PLC、bFGF表达与HCC临床病理指标及转移复发无关;但PLC和bFGF共表达与HCC转移复发有关(P＜0.05).结论:所建立的PLC阳性判断标准具有一定的合理性,PLC和bFGF可能参与HCC转移复发和血管生成,二者共表达可以预测HCC转移复发.

Objective To establish initially a positive standard of perlcecan (PLC) for immunohistochemical study (IHC), and explore the distribution characteristic of PLC in hepatocellular carcinoma (HCC) and its relationship with metastatic recurrence of HCC.Methods The distributions of PLC, and its ligand, basic fibroblast growth factor (bFGF) in HCC were detected with SP method of IHC, and the positive standard of PLC in HCC was established on the basis of distribution characteristic of PLC, then the relationship between PLC or bFGF expressions and metastatic recurrence of HCC was analyzed. Results An positive standard of perlcecan for IHC was initially established, continuous or discontinuous lineal staining of PLC along basement membrane was observed in partial HCC patients while buffy dyeing in the cytoplasm and membrane of cancer cell in other cases, and bFGF staining was mainly showed as brown granular in the cytoplasm and membrane of cancer cell, both the expression rate of bFGF and coexpression rate of PLC and bFGF in tumor tissue were significantly higher than those in corresponding non-cancerous liver tissue (P<0.05,0.01,respectively).Although expression of PLC or bFGF was independent of the clinical-pathologic indexes and metastatic recurrence of HCC, coexpression of PLC and bFGF was related with metastatic recurrence of HCC(P<0.05). Conclusion The the positive standard of PLC is reasonable to certain extent, and PLC and bFGF may play important roles in the metastatic recurrence and angiogenesis. The coexpression help predict postoperative metastatic recurrence of HCC.

参考文献：

[1] IOZZ0 R V, SAN-ANTONIO J D. Heparan sulfate proteoglycans:heavy hitters in the angiogenesis arena. 2001(3)
[2] NOONAN D M, FULLE A, VALENTE P. The complete sequence of perlecan,a basement membrane heparan sulfate proteoglycan,reveals extensive similarity with laminin A chain,low density lipoprotein-receptor,and the neural cell adhesion melecule, 1991(34)
[3] AVIEZER D, HECHT D, SAFRAN M. Perlecan,basal lamina proteoglycan,promotes basic fibroblast growth factor-receptor binding,mitogenesis,and angiogensis. 1994(6). doi:10.1016/0092-8674(94)90031-0
[4] 晋光荣, 刘培党, 张忠红. 局灶性脑缺血再灌注损伤对大鼠延髓内脏带NOS阳性神经元与FOS蛋白表达的影响. 东南大学学报(医学版)2001(4). doi:10.3969/j.issn.1671-6264.2001.04.001
[5] MATTERN J, KOOMAGI R, VOLM M. Biological characterization of subgroups of squamous cell lung carcinomas, 1999(6)
[6] ROSKAMS T, MOSHAGE H, DE-VOS R. Heparan sulfate proteoglycan expression in norm al human liver. 1995(4). doi:10.1002/hep.1840210410
[7] ROSKAMS T, DE-VOS R, DAVID G. Heparan sulfate proteoglycan expression in human primary liver tumors, 1998
[8] LJUBIMOV A V, BARTEK J, COUCHMAN J R. Distribution of individual components of basement membrane in human colon polyps and adenocarcinomas as revealed by monoclonal antibodies. 1992(4). doi:10.1002/ijc.2910500412
[9] SABIT H, TSUNEYAMA K, SHIMONISHI T. Enhanced expression of basement-membrane-type heparan sulfate proteoglycan in tumor fibro-myxiod stroma of intrahepatic cholaniocarcinoma. 2001. doi:10.1046/j.1440-1827.2001.01201.x
[10] KNOX S, MERRY C, STRINGER S. Not all perlecans are created equel:interactions with fibroblast growth factor 2 (FGF-2) and FGF receptors, 2002(17)
[11] MATHIAK M, YENISEYC, GRANT D S, etal. A role for perecan in the suppression of growth and invasion in fibrosarcoma cells, 1997(11)
[12] TOVARI J, PAKU S, RASO E. Role of sinusoidal heparan sulfate proteoglycan in liver metastasis formation. 1997(5). doi:10.1002/(SICI)1097-0215(19970529)71:5&lt, 825::AID-IJC21&gt, 3.0.CO, 2-5

服务与反馈：

【文章下载】【发表评论】【查看评论】【加入收藏】

提示：您还未登录，请登录！点此登录